Related references
Note: Only part of the references are listed.Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleuldn-1 Blockade
Vitaly Ablamunits et al.
DIABETES (2012)
Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data
Carla J. Greenbaum et al.
DIABETES (2012)
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Diane K. Wherrett et al.
LANCET (2011)
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial
Nicole Sherry et al.
LANCET (2011)
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban et al.
LANCET (2011)
Acquisition of regulatory function by human CD8+ T cells treated with anti-CD3 antibody requires TNF
Vitaly Ablamunits et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Jeffrey A. Bluestone et al.
NATURE (2010)
Autoimmune-Mediated Oxidative Stress and Endothelial Dysfunction: Implications of Accelerated Vascular Injury in Type I Diabetes
Michael A. Zimmerman et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose
R. Rubinstein et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
β-Cell Mass and Type 1 Diabetes Going, Going, Gone?
Eitan Akirav et al.
DIABETES (2008)
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Carla J. Greenbaum et al.
DIABETES CARE (2008)
GAD treatment and insulin secretion in recent-onset type 1 diabetes
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
B Bisikirska et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
KC Herold et al.
DIABETES (2005)
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
MK Levings et al.
BLOOD (2005)
Insulin secretion in type 1 diabetes
C Steele et al.
DIABETES (2004)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
